Icaritin Soft Capsule Versus Huachansu Tablet in the First-line Treatment of Unresectable Hepatocellular Carcinoma With Poor Conditions and Biomarker Enrichment (Biomarker Enrichment Study of Poor Prognosis HCC Patients, BESTPOP)
Clinical trial NCT05594927 · RECRUITING
Trial details
- NCT number
- NCT05594927
- Sponsor
- Beijing Shenogen Biomedical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2022-12-12
- Primary completion
- 2025-08-30
- Enrollment
- 261
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.